Last reviewed · How we verify
preservative-free parenteral treprostinil
preservative-free parenteral treprostinil is a Prostacyclin analog Small molecule drug developed by AOP Orphan Pharmaceuticals AG. It is currently in Phase 3 development for Pulmonary arterial hypertension (PAH).
Treprostinil mimics the action of prostacyclin, which is a natural substance that dilates blood vessels and prevents platelet aggregation.
Treprostinil mimics the action of prostacyclin, which is a natural substance that dilates blood vessels and prevents platelet aggregation. Used for Pulmonary arterial hypertension (PAH).
At a glance
| Generic name | preservative-free parenteral treprostinil |
|---|---|
| Sponsor | AOP Orphan Pharmaceuticals AG |
| Drug class | Prostacyclin analog |
| Target | Prostacyclin receptor (IP receptor) |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
By binding to and activating prostacyclin receptors, treprostinil promotes vasodilation and reduces pulmonary arterial pressure, thereby improving symptoms and outcomes in patients with pulmonary arterial hypertension.
Approved indications
- Pulmonary arterial hypertension (PAH)
Common side effects
- Headache
- Nausea
- Dizziness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- preservative-free parenteral treprostinil CI brief — competitive landscape report
- preservative-free parenteral treprostinil updates RSS · CI watch RSS
- AOP Orphan Pharmaceuticals AG portfolio CI
Frequently asked questions about preservative-free parenteral treprostinil
What is preservative-free parenteral treprostinil?
How does preservative-free parenteral treprostinil work?
What is preservative-free parenteral treprostinil used for?
Who makes preservative-free parenteral treprostinil?
What drug class is preservative-free parenteral treprostinil in?
What development phase is preservative-free parenteral treprostinil in?
What are the side effects of preservative-free parenteral treprostinil?
What does preservative-free parenteral treprostinil target?
Related
- Drug class: All Prostacyclin analog drugs
- Target: All drugs targeting Prostacyclin receptor (IP receptor)
- Manufacturer: AOP Orphan Pharmaceuticals AG — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Pulmonary arterial hypertension (PAH)
- Compare: preservative-free parenteral treprostinil vs similar drugs
- Pricing: preservative-free parenteral treprostinil cost, discount & access